U.S. markets open in 7 hours 5 minutes
  • S&P Futures

    4,080.25
    -9.75 (-0.24%)
     
  • Dow Futures

    34,078.00
    -78.00 (-0.23%)
     
  • Nasdaq Futures

    12,116.50
    -35.50 (-0.29%)
     
  • Russell 2000 Futures

    1,935.10
    -4.30 (-0.22%)
     
  • Crude Oil

    79.08
    +0.21 (+0.27%)
     
  • Gold

    1,942.90
    -2.40 (-0.12%)
     
  • Silver

    23.77
    -0.06 (-0.26%)
     
  • EUR/USD

    1.0880
    +0.0014 (+0.13%)
     
  • 10-Yr Bond

    3.5290
    0.0000 (0.00%)
     
  • Vix

    19.40
    -0.54 (-2.71%)
     
  • GBP/USD

    1.2320
    +0.0003 (+0.02%)
     
  • USD/JPY

    130.3720
    +0.3040 (+0.23%)
     
  • BTC-USD

    23,096.06
    +219.61 (+0.96%)
     
  • CMC Crypto 200

    524.33
    +5.54 (+1.07%)
     
  • FTSE 100

    7,771.70
    -13.17 (-0.17%)
     
  • Nikkei 225

    27,346.88
    +19.77 (+0.07%)
     

Orthofix Medical Announces Participation in Upcoming Stifel Healthcare Conference

LEWISVILLE, Texas, November 10, 2022--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, today announced that President and Chief Executive Officer Jon Serbousek and Chief Financial Officer Doug Rice will participate in a fireside chat during the upcoming Stifel 2022 Healthcare investor conference on Wednesday, November 16, 2022 at 8:00 a.m. ET. The conference will be held live at the Lotte New York Palace in NYC and one-on-one meetings will be held immediately following the fireside chat.

The presentation will be available live and for replay for ninety days on the Company’s website at ir.orthofix.com/events-and-presentations/.

About Orthofix

Orthofix Medical Inc. is a global medical device company with a spine and orthopedics focus. The Company’s mission is to deliver innovative, quality-driven solutions while partnering with health care professionals to improve patient mobility. Headquartered in Lewisville, Texas, Orthofix’s spine and orthopedics products are distributed in more than 60 countries via the Company's sales representatives and distributors. For more information, please visit www.orthofix.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221110005317/en/

Contacts

Alexa Huerta
Investor Relations
Tel 214 937 3190
alexahuerta@orthofix.com

Denise Landry
Media Relations
Tel 214 937 2529
deniselandry@orthofix.com